The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Calcitonin Gene–Related Peptide Receptor Antagonist BIBN 4096 BS for the Acute Treatment of Migraine
Open accessAbstract
BACKGROUND: Calcitonin gene-related peptide (CGRP) may have a causative role in migraine. We therefore hypothesized that a CGRP-receptor antagonist might be effective in the treatment of migraine attacks. METHODS: In an international, multicenter, double-blind, randomized clinical trial of BIBN 4096 BS, a highly specific and potent nonpeptide CGRP-receptor antagonist, 126 patients with migraine received one of the following: placebo or 0.25, 0.5, 1, 2.5, 5, or 10 mg of BIBN 4096 BS intravenously over a period of 10 minutes. A group-sequential adaptive treatment-assignment design was used to minimize the number of patients exposed. RESULTS: The 2.5-mg dose was selected, with a response rate of 66 percent, as compared with 27 percent for placebo (P=0.001). The BIBN 4096 BS group as a whole had a response rate of 60 percent. Significant superiority over placebo was also observed with respect to most secondary end points: the pain-free rate at 2 hours; the rate of sustained response over a period of 24 hours; the rate of recurrence of headache; improvement in nausea, photophobia, phonophobia, and functional capacity; and the time to meaningful relief. An effect was apparent after 30 minutes and increased over the next few hours. The overall rate of adverse events was 25 percent after the 2.5-mg dose of the drug and 20 percent for the BIBN 4096 BS group as a whole, as compared with 12 percent for placebo. The most frequent side effect was paresthesia. There were no serious adverse events. CONCLUSIONS: The CGRP antagonist BIBN 4096 BS was effective in treating acute attacks of migraine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Goadsby, P. J. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00711.x · Cited by 2,381
Self-citationPrevalence and Burden of Migraine in the United States: Data From the American Migraine Study II
Lipton, R. B., Stewart, W. F., Diamond, S., Diamond, M. L., & Reed, M. (2001) · Headache: The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.2001.041007646.x · Cited by 2,268
Migraine — Current Understanding and Treatment
Goadsby, P. J., Lipton, R. B., & Ferrari, M. D. (2002) · New England Journal of Medicine · doi:10.1056/nejmra010917 · Cited by 1,918
Self-citationVasoactive peptide release in the extracerebral circulation of humans during migraine headache
Goadsby, P. J., Edvinsson, L., & Ekman, R. (1990) · Annals of Neurology · doi:10.1002/ana.410280213 · Cited by 1,597
Self-citationIs the Placebo Powerless?: An Analysis of Clinical Trials Comparing Placebo with No Treatment
Hróbjartsson, A., & Gøtzsche, P. C. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105243442106 · Cited by 1,503
Group Sequential Methods with Applications to Clinical Trials
Jennison, C., & Turnbull, B. W. (1999) · Chapman & Hall/CRC eBooks · doi:10.1201/9780367805326 · Cited by 1,336
Goadsby, P. J., & Edvinsson, L. (1993) · Annals of Neurology · doi:10.1002/ana.410330109 · Cited by 1,158
Self-citationThe Global Burden of Disease Study: Implications for Neurology
Menken, M., Munsat, T. L., & Toole, J. F. (2000) · Archives of Neurology · doi:10.1001/archneur.57.3.418 · Cited by 1,058
Cgrp May Play A Causative Role in Migraine
Lassen, L., Haderslev, P., Jacobsen, V., Iversen, H., Sperling, B., & Olesen, J. (2002) · Cephalalgia · doi:10.1046/j.1468-2982.2002.00310.x · Cited by 1,027
Self-citationFerrari, M. D., Roon, K. I., Lipton, R. B., & Goadsby, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06711-3 · Cited by 987
Self-citationGoadsby, P. J., Edvinsson, L., & Ekman, R. (1988) · Annals of Neurology · doi:10.1002/ana.410230214 · Cited by 863
Self-citationCerebral Blood Flow and Metabolism
Edvinsson, L., MacKenzie, E. T., & McCulloch, J. (1994) · Headache: The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.1994.hed3401059.x · Cited by 762
Guidelines for Controlled Trials of Drugs in Migraine: Second Edition
International Headache Society Clinical Trials Subcommittee, Tfelt-Hansen, P., Block, G., Dahlöf, C., Diener, H.-C., Ferrari, M., Goadsby, P., Guidetti, V, Jones, B., Lipton, R., et al. (2000) · Cephalalgia · doi:10.1046/j.1468-2982.2000.00117.x · Cited by 698
Self-citationPharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
Doods, H., Hallermayer, G., Wu, D., Entzeroth, M., Rudolf, K., Engel, W., & Eberlein, W. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703110 · Cited by 466
Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250504 · Cited by 448
Uddman, R., Edvinsson, L., Ekman, R., Kingman, T., & McCulloch, J. (1985) · Neuroscience Letters · doi:10.1016/0304-3940(85)90296-4 · Cited by 408
Symptomatic and nonsymptomatic headaches in a general population
Rasmussen, B. K., & Olesen, J. (1992) · Neurology · doi:10.1212/wnl.42.6.1225 · Cited by 366
Self-citationBuzzi, M. (1991) · Neuropharmacology · doi:10.1016/0028-3908(91)90165-8 · Cited by 318
Treatment of migraine attacks with sumatriptan
Milne, L. (1992) · The Journal of Emergency Medicine · doi:10.1016/0736-4679(92)90247-q · Cited by 252
Goadsby, P. J. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00010-1 · Cited by 237
Self-citationJennison, C., & Turnbull, B. (1999) · Chapman & Hall/CRC Interdisciplinary Statistics Series · doi:10.1201/9781584888581 · Cited by 210
Petersen, K., Birk, S., Lassen, L., Kruuse, C., Jonassen, O., Lesko, L., & Olesen, J. (2005) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00830.x · Cited by 181
Self-citationAkerman, S., Williamson, D. J., Kaube, H., & Goadsby, P. J. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704842 · Cited by 175
Self-citationWilliamson, D., Hargreaves, R., Hill, R., & Shepheard, S. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1704518.x · Cited by 170
Williamson, D., Hargreaves, R., Hill, R., & Shepheard, S. (1997) · Cephalalgia · doi:10.1046/j.1468-2982.1997.1704525.x · Cited by 159
Möller, S. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140909 · Cited by 156
Jansen‐Olesen, I., Mortensen, A., & Edvinsson, L. I. (1996) · Cephalalgia · doi:10.1046/j.1468-2982.1996.1605310.x · Cited by 154
Storer, R. J. (1997) · Brain · doi:10.1093/brain/120.12.2171 · Cited by 133
Jansen, I., Uddman, R., Ekman, R., et al. (1992) · Peptides · doi:10.1016/0196-9781(92)90084-g · Cited by 100
Jansen, I., Uddman, R., Hocherman, M., et al. (1986) · Annals of Neurology · doi:10.1002/ana.410200409 · Cited by 87
Moreno, M. J. L., Abounader, R., Hébert, E., Doods, H. N., & Hamel, É. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00008-4 · Cited by 79
Placebo Response in Clinical Randomized Trials of Analgesics in Migraine
Bendtsen, L., Mattsson, P., Zwart, J.-A., & Lipton, R. B. (2003) · Cephalalgia · doi:10.1046/j.1468-2982.2003.00528.x · Cited by 78
Cerebral Blood Flow and Metabolism, 2nd edition
Jellinger, K. A. (2002) · European Journal of Neurology · doi:10.1046/j.1468-1331.2002.t01-7-00388.x · Cited by 33
Solano (2000) · doi:10.1002/1531-8249(200002)47:2 · Cited by 3
Cited by
Pathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998
Self-citationCalcitonin Gene-Related Peptide: Physiology and Pathophysiology
Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,258
CGRP as the target of new migraine therapies — successful translation from bench to clinic
Edvinsson, L., Haanes, K. A., Warfvinge, K., & Krause, D. N. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0003-1 · Cited by 999
A Controlled Trial of Erenumab for Episodic Migraine
Goadsby, P. J., Reuter, U., Hallström, Y., Broessner, G., Bonner, J. H., Zhang, F., Sapra, S., Picard, H., Mikol, D. D., & Lenz, R. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1705848 · Cited by 928
Self-citationPietrobon, D., & Moskowitz, M. A. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183717 · Cited by 680
Metadata
- Authors
- Olesen, J., Diener, H.-C., Husstedt, I. W., Goadsby, P. J., Hall, D., Meier, U., Pollentier, S., & Lesko, L. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2004-03-11
- Volume
- 350
- Issue
- 11
- Pages
- 1104-1110
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2048132386
- Cited by
- 1,189
- References
- 34
- FWCI
- 38.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.